Glipizide Bp Galena

Glipizide Bp Galena is a prescription oral medication that contains the active ingredient glipizide, a sulfonylurea class drug used to manage blood glucose levels in adults with type 2 diabetes mellitus. It is marketed in the European Union and is taken by mouth as directed by a healthcare professional.

Glipizide Bp Galena is indicated for the treatment of type 2 diabetes mellitus when diet, exercise, and other non‑pharmacologic measures are insufficient to achieve glycemic control.

- Improves fasting and post‑prandial blood glucose levels. - Used as part of a comprehensive diabetes management plan that includes diet and exercise. - May be combined with other antidiabetic agents when monotherapy is inadequate. - Helps reduce HbA1c levels in patients with established type 2 diabetes. - Prescribed for adults who have not achieved target glucose levels with lifestyle changes alone.

Glipizide Bp Galena can cause a range of side effects, most of which are mild and transient, but some may require medical attention.

Common: - Low blood sugar (hypoglycemia) symptoms such as shakiness, sweating, or dizziness. - Nausea or upset stomach. - Headache. - Weight gain. - Skin rash or itching.

Serious: - Severe hypoglycemia leading to loss of consciousness. - Allergic reactions including swelling of the face, lips, or throat. - Liver function abnormalities. - Blood disorders such as leukopenia or thrombocytopenia.

Before starting Glipizide Bp Galena, certain health considerations should be reviewed to ensure safe use.

- Assess renal and hepatic function, as impairment may affect drug clearance. - Monitor blood glucose regularly to detect hypoglycemia early. - Use caution in elderly patients who may be more sensitive to low blood sugar. - Discuss any history of allergic reactions to sulfonylureas. - Inform the prescriber of pregnancy or breastfeeding status, as safety data are limited. - Review concomitant use of other glucose‑lowering agents to avoid additive effects.

Glipizide Bp Galena may interact with several medications, altering its efficacy or safety profile.

Avoid: - Other sulfonylureas or insulin, which can increase the risk of severe hypoglycemia. - Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that may raise glipizide levels. - Certain diuretics that can affect blood glucose control.

Use with caution: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may mask hypoglycemia symptoms. - Beta‑blockers, which can blunt typical hypoglycemia warning signs. - Antidepressants such as SSRIs that may influence glucose metabolism.